Covid-19
Review: COVID-19-associated coagulopathy and antithrombotic agents – In non-critically ill hospitalized patients, therapeutic dose anticoagulation may improve clinical outcomes. In critically ill patients, this same treatment does not improve outcomes, and prophylactic dose anticoagulation is recommended
29 Apr, 2021 | 08:46h | UTCRelated: Full-dose Heparin best for moderate COVID-19 regardless of D-dimer — Data released from ACTIV-4a, ATTACC, and REMAP-CAP trials AND RCT: Intermediate-dose enoxaparin (1 mg/kg/d) not better than standard-dose prophylactic anticoagulation in patients with Covid-19 admitted to the intensive care unit
Commentary on Twitter
🆕💥💥State of the Art Review Article @TheLancetHaem by @MiddeldorpS
COVID-19-associated coagulopathy
Excellent explanation for the pathophysiology and great summary for the major RCTs and clinical guidelines https://t.co/NxP06KP2Hm pic.twitter.com/qHzyDsUZpt— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) April 28, 2021
India’s surge leads to further global COVID rise as role of variants probed
29 Apr, 2021 | 08:41h | UTCIndia’s surge leads to further global COVID rise as role of variants probed – CIDRAP
See also: India Blames a Virus Variant as Its Covid-19 Crisis Deepens – The New York Times (free registration required) AND Why the COVID-19 Variants Spreading in India Are a Global Concern – TIME
Commentary on Twitter (thread – click for more)
Variant? “The current 🇮🇳 wave of #COVID19 has a different clinical behavior. It’s affecting young adults. It’s affecting families. It’s a new thing altogether. Two-month-old babies are getting infected.” Also many reports of reinfections/breakthroughs.🧵https://t.co/qve23lduGb pic.twitter.com/FFIBaFsh0J
— Eric Feigl-Ding (@DrEricDing) April 28, 2021
Brazilian regulatory authorities decide not to approve the Gamaleya vaccine
29 Apr, 2021 | 08:38h | UTCBrazil Rejects the Gamaleya Vaccine – Science Translational Medicine
See also: Russia’s Sputnik V developers reject Brazil’s criticisms – Reuters
CDC Study: Pfizer-BioNTech and Moderna vaccines reduce Covid-19 hospitalization risk by 64% after the first dose and 94% after the second dose among adults aged ≥65 years
29 Apr, 2021 | 08:42h | UTCCommentaries: Pfizer/Moderna Vaccine Protection: 64% at First Dose, 94% at Second – HealthDay AND Pfizer and Moderna vaccines reduce Covid-19 hospitalization risk by 94% among older adults, CDC study says – CNN
Commentary on Twitter
New @CDCMMWR has good news: mRNA COVID-19 vaccines (Pfizer-BioNTech, Moderna) reduced the risk of #COVID19-related hospitalization by 94% among fully vaccinated people 65+. CDC recommends getting a COVID-19 vaccine to prevent severe COVID-19 illness: https://t.co/W4SFuV6wQp. pic.twitter.com/Jf4ph2rl4s
— CDC (@CDCgov) April 28, 2021
Ethics Commission Position Statement: Admission criteria and management of critical care patients in a pandemic context – “Age cannot be used as the sole criterion for admission nor denial of access to ICU settings”
29 Apr, 2021 | 08:36h | UTC
China May Become World’s Biggest Vaccine Supplier As India Defaults On Global Deliveries
29 Apr, 2021 | 08:39h | UTC
Review: Systemic and organ-specific immune-related manifestations of COVID-19 – over 70 different systemic and organ-specific immune-related disorders have been reported
28 Apr, 2021 | 08:42h | UTCSystemic and organ-specific immune-related manifestations of COVID-19 – Nature Reviews Rheumatology
CDC says fully vaccinated Americans can go outside without masks – but masks still needed in crowds
28 Apr, 2021 | 08:44h | UTCCDC Guidance: Choosing Safer Activities – Centers for Disease Control and Prevention
Commentaries: CDC: If You’re Vaccinated, You Don’t Need To Mask Outdoors (Unless You’re In A Crowd) – NPR AND CDC: Fully vaccinated Americans can go maskless outdoors – CIDRAP
Commentary on Twitter (thread – click for more)
If you are fully vaccinated against #COVID19, you can start doing many things that you had stopped doing because of the pandemic. If you haven’t been vaccinated yet, get a vaccine as soon as you can. See full details: https://t.co/s5kXwg65fB pic.twitter.com/fvhehUiiCi
— CDC (@CDCgov) April 27, 2021
Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile
28 Apr, 2021 | 08:41h | UTC
Commentary on Twitter
An analysis of #COVID19 incidence and mortality in Santiago, Chile, highlights major consequences of healthcare disparities in a highly segregated city, showing that these inequalities disproportionately affected younger people @OxfordStats @HarvardChanSPH https://t.co/8f2Q2PdqBj pic.twitter.com/Ip1cikxvi7
— Science Magazine (@ScienceMagazine) April 27, 2021
Covid-19 in India: Cases, deaths and oxygen supply
28 Apr, 2021 | 08:40h | UTCCovid-19 in India: Cases, deaths and oxygen supply – BBC
See also: In Covid’s grip, India gasps for air: ‘If there is an apocalypse, this has to be one’ – STAT
How the UK found the first effective Covid-19 treatment — and saved a million lives (about the RECOVERY trial and the effects of Dexamethasone)
28 Apr, 2021 | 08:36h | UTCHow the UK found the first effective Covid-19 treatment — and saved a million lives – Vox
Related: Covid-19: The Inside Story of the RECOVERY Trial AND Covid: The London bus trip that saved maybe a million lives – BBC
Scientists say the rush to do Covid research led to a whole lot of waste
28 Apr, 2021 | 08:34h | UTCScientists Say The Rush To Do COVID Research Led To A Whole Lot Of Waste – NPR
Original Article: How COVID-19 has fundamentally changed clinical research in global health – The Lancet Global Health
Related: Data Show Panic and Disorganization Dominate the Study of Covid-19 Drugs (other commentaries on the subject)
See also: The Lancet Series: Clinical Trials in Global Health
Commentary on Twitter (thread – click for more)
Quantity > quality? The magnitude of #COVID19 research of questionable methodological quality reveals an urgent need to optimise clinical trial research—but how?
A new @LancetGH Series discusses challenges and solutions. Read https://t.co/z4SluR3yuh 1/5 pic.twitter.com/94RRVT0qhF
— The Lancet (@TheLancet) April 16, 2021
Tracking the Evolution of a ‘Variant of Concern’ in Brazil – “P.1 may be 1.7 to 2.4 times more transmissible than earlier variants”
28 Apr, 2021 | 08:38h | UTCTracking the Evolution of a ‘Variant of Concern’ in Brazil – NIH Director’s Blog
Related: Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil – Science
Overview of SARS-CoV-2 infection in adults living with HIV – Low CD4 cell counts, or untreated HIV infection is associated a more severe clinical course
28 Apr, 2021 | 08:32h | UTCOverview of SARS-CoV-2 infection in adults living with HIV – The Lancet HIV
Commentary on Twitter
New Review: Overview of SARS-CoV-2 infection in adults living with HIV: https://t.co/xXTntfIYPF pic.twitter.com/6w6MUSbo3n
— The Lancet HIV (@TheLancetHIV) April 27, 2021
Immunization services begin slow recovery from COVID-19 disruptions, though millions of children remain at risk from deadly diseases – WHO, UNICEF, Gavi
27 Apr, 2021 | 08:41h | UTCRelated report: Disability considerations for COVID-19 vaccination: WHO and UNICEF policy brief, 19 April 2021 – World Health Organization
Commentary on Twitter
While immunization services begin slow recovery from #COVID19, millions of children around the 🌍🌏🌎 remain vulnerable to deadly diseases.
More info 👉https://t.co/YjskC8z6nc pic.twitter.com/SEv8d2VSAB
— World Health Organization (WHO) (@WHO) April 26, 2021
Why the World Should Worry About India – “The world’s largest vaccine producer is struggling to overcome its latest COVID-19 surge—and that’s everyone’s problem.”
27 Apr, 2021 | 08:33h | UTCWhy the World Should Worry About India – The Atlantic
See also: Covid-19: Countries rally to support India through “storm that has shaken the nation” – The BMJ AND As India breaks another global Covid-19 record and hospitals run out of oxygen, countries pledge assistance and aid – CNN AND India’s COVID-19 crisis prompts global response – CIDRAP
Study in nursing homes shows rapid antigen testing could be a useful tool to identify contagious people at risk for transmitting SARS-CoV-2
27 Apr, 2021 | 08:35h | UTCEditorial: Utility of Rapid Antigen Tests in Nursing Homes
Commentary on Twitter
💥🆕 Despite lower positive agreement compared with RT-PCR, antigen test positivity had higher agreement with shedding of replication-competent virus. These results suggest that antigen testing could be a useful tool to rapidly identify contagious people. https://t.co/Dlw7ttLlSL pic.twitter.com/sGmfVIy02H
— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) April 26, 2021
M-A: Prophylaxis against Covid-19: 1 – no benefit from Hydroxychloroquine; 2 – as studies on ivermectin so far have been small, it remains very uncertain whether ivermectin reduces SARS-CoV-2 infection
27 Apr, 2021 | 08:44h | UTCProphylaxis against covid-19: living systematic review and network meta-analysis – The BMJ
The Utility of Chest CT imaging in suspected or diagnosed COVID-19 Patients – a review of literature
27 Apr, 2021 | 08:30h | UTC
Opinion | Real-world data, not predictions, should drive decisions on Covid-19 and school opening
27 Apr, 2021 | 08:26h | UTCReal-world data, not predictions, should drive decisions on Covid-19 and school opening – STAT
Commentary from the author on Twitter
Real-world data, not predictions, should drive decisions on Covid-19 and school opening with @elbeezuchdt @citizen_oregon: Concept is simple. Schools are half/closed due to alarmist inaccurate models. Use real-world data to drive our decisions on kids.https://t.co/HfZl8IAVXq
— Monica Gandhi MD, MPH (@MonicaGandhi9) April 23, 2021
Clinical Manifestation, Evaluation, and Rehabilitative Strategy of Dysphagia Associated With COVID-19
27 Apr, 2021 | 08:29h | UTC
Covid-19: Infections fell by 65% after first dose of AstraZeneca or Pfizer vaccine, data show
25 Apr, 2021 | 22:06h | UTC
Commentary on Twitter (thread – click for more)
Over one year into the #COVID19 pandemic, about 9⃣0⃣% of countries surveyed still report one or more disruptions to essential health services. Major efforts are required to restore and strengthen services in all countries.
👉 https://t.co/P34xPKY1Io pic.twitter.com/UYDQPX67Vw
— World Health Organization (WHO) (@WHO) April 23, 2021
Clinical review of 43 patients with COVID-19-associated Acute Transverse Myelitis and 3 patients with Acute Transverse Myelitis reported post-vaccination
27 Apr, 2021 | 08:32h | UTCCommentary: Rare neurological condition linked to COVID-19 cases in 21 countries – Houston Methodist
SARS-CoV-2 and Stroke Characteristics – higher rate of large vessel occlusions and stroke in young patients
25 Apr, 2021 | 22:01h | UTC
Commentary on Twitter
SARS-CoV-2 and #Stroke Characteristics: A Report From the Multinational COVID-19 Stroke Study Group #COVID19 #AHACOVID19 #AHAJournals @cgriessenauer @ArKatsanos https://t.co/Errp6MjQMV pic.twitter.com/QX5tAGQOXU
— Stroke AHA/ASA (@StrokeAHA_ASA) April 21, 2021
Opinion | The International Community Has One Job: Getting COVID-19 Under Control
25 Apr, 2021 | 22:09h | UTC
Commentary on Twitter
India is in a crisis of unimaginable scale & predictable severity–and our international leadership is MIA and ready to move on. Pull it together & do your ONE JOB: getting the entire world out of the COVID mass casualty catastrophe.
w/@glassmanamanda https://t.co/0Xj3KZgUTh
— Rachel Bonnifield (@rachelbnfield) April 23, 2021


